Slides TanLie Sie

Embed Size (px)

Citation preview

  • 8/7/2019 Slides TanLie Sie

    1/27

    CONTROL OF DIETARY

    SUPPLEMENTS INMALAYSIA

    CONTROL OF DIETARY

    SUPPLEMENTS INMALAYSIA

    TAN LIE SIE

    DRUG EVALUATION AND SAFETY DIVISIONNATIONAL PHARMACEUTICAL CONTROL BUREAU

    MINISTRY OF HEALTH MALAYSIA

    Seminar on dietary supplements - 15 January 2004

  • 8/7/2019 Slides TanLie Sie

    2/27

    CONTENTS

    Food / Drug Interface

    Regulatory Process in Malaysia

    Concerns

    Conclusion

  • 8/7/2019 Slides TanLie Sie

    3/27

    What is this interface?

    - interaction of 2 regulatoryregimes;

    - no internationallystandardised approach;

    - complex, with public health andsafety implications

    FOOD/DRUG INTERFACE

  • 8/7/2019 Slides TanLie Sie

    4/27

    Guide to Classification of Food-Drug Interface Products(Guide to determining if a product is to be regulated by the NPCB/FQC)

    Product

    Ingredients

    Pure Form of active

    ingredient (singly or in

    combination)

    Natural product that are not

    traditionally used as food and of

    medicinal value

    Food base

    jVitamin

    jmineraljamino acidjFatty acid

    jFibre

    jLyophilizedBacteriajEnzyme

    yAlfalfa tablets

    ySpirulinayRoyal Jelly

    yNoni Juice

    yPegaga tablet

    yHerbal product

    80% or more

    Food base

    Less than 80% food base or more

    than 20% active ingredients of

    natural products. But if the latterpossess high potencies, the product

    shall be reviewed by the Committee,

    even if they contain less than 20% of

    these ingredients.NPCB-National Pharmaceutical Control Bureau

    FQC Food Quality Control Division

    If a product is more than 80% food based but contains pure forms of active ingredient (e.g.: vitamins & minerals) that exceed the amounts permitted in Food Regulations 1985,

    the company shall be advised to reduce the amounts of these active ingredients and be regulated by FQC.

    Intended use and claim should not be used as sole criteria for classification but can be used as a guide Instruction for use and pharmaceutical dosage form like tablet, capsule, should not be used as criteria for classification but can be used as a guide.

  • 8/7/2019 Slides TanLie Sie

    5/27

    If a product contains less than 80% of food-based ingredients and more than 20% ofthe active ingredients, such product shallbe regulated by NPCB. Not withstandingthis general rule, for specific ingredientswhich possess high potencies, even if theycontain less than 20% of the active

    ingredients, they shall be reviewed by thecommittee and may be regulated by NPCBif it is found necessary

    FOOD/DRUG INTERFACE

  • 8/7/2019 Slides TanLie Sie

    6/27

    If a product is more than 80% food basedbut

    contains pure forms of active ingredient(e.g.: vitamins & minerals) that exceed theamounts permitted in Food Regulations1985,

    the company shall be advised to reduce the

    amounts of these active ingredients and be

    regulated by BKMM.

    FOOD/DRUG INTERFACE

  • 8/7/2019 Slides TanLie Sie

    7/27

    Following criteria should not be used assole criteria for classification but can beused as a guide

    Intended use and claim

    Instruction for use and ph

    armaceuticaldosage forms like tablet, capsule, etc

    FOOD/DRUG INTERFACE

  • 8/7/2019 Slides TanLie Sie

    8/27

    DRUG CONTROL AUTHORITY

    NATIONAL PHARMACEUTICAL

    CONTROL BUREAU (NPCB)(as Secretariat / Executive Arm)

  • 8/7/2019 Slides TanLie Sie

    9/27

    DRUGCONTROLAUTHORITY

    (DCA)

    Register all drugs (prescription, over-the-

    counter andh

    erbal medicines) and cosmeticproducts

    License manufacturers, importers andwholesalers of registered products

    Monitor the quality and safety of marketedproducts through Post-Registration MarketSurveillance & Adverse Drug ReactionsReporting

  • 8/7/2019 Slides TanLie Sie

    10/27

    The Control ofDrugs and

    Cosmetics Regulations 1984

    Regulation 7(1)(a) requiresALLproducts to beregistered with the DCA prior to beingimported, manufactured, sold or supplied,unless the product is exempted under specific

    provisions of these Regulations.

  • 8/7/2019 Slides TanLie Sie

    11/27

    The Control ofDrugs and

    Cosmetics Regulations 1984

    A productas defined in the Regulations,means a drug in a pharmaceutical dosageform, or a cosmetic, having a singularidentity, composition, characteristics and

    origin.

  • 8/7/2019 Slides TanLie Sie

    12/27

    The Control ofDrugs and

    Cosmetics Regulations 1984A drugis used on humans (and animals)

    to prevent, cure, treat, or reduce illness ,

    to diagnose disease, for contraception,

    to induce anaesthesia (sedate),

    to change or to control physiological function,

    to control body weight,

    general maintenance or promotion of health orwell being

  • 8/7/2019 Slides TanLie Sie

    13/27

    DIETARYSUPPLEMENTS

    Products intended to supplement the diet,taken by mouth in forms such as pills,

    capsules, tablets, liquids or powders and notrepresented as conventional food.

    May include ingredients such as

    Vitamins, Minerals, Amino Acids,Natural Substances of plant/animal origin,Enzymes

    Substances with nutritional / physiologicalfunction

  • 8/7/2019 Slides TanLie Sie

    14/27

    Why register dietary

    supplements?

    Need to protect consumer interests

    * Record of products registered andtheir respective responsiblemarket authoriztion holders andmanufacturers

    * Monitoring and enforcement* Regulate claims

    * Safety aspects

  • 8/7/2019 Slides TanLie Sie

    15/27

    REGISTRATIONCRITERIA

    SAFETY

    Products will not be registered if there arepublic health concerns based on safetyconsiderations (ingredients used, combinations)

    Upper daily limits set for some vitamins andminerals

    Warnings/precautions may be required in

    product labelling

  • 8/7/2019 Slides TanLie Sie

    16/27

    REGISTRATIONCRITERIA

    QUALITY

    Have to comply with current Good ManufacturingPractices (cGMP) requirements

    - infrastructure /facilities

    - personnel

    - processes and controls

    Sh

    ould conform to set standards of quality- raw materials

    - finished product

    - stability testing

  • 8/7/2019 Slides TanLie Sie

    17/27

    REGISTRATIONCRITERIA

    CLAIMS ( EFFICACY )

    Supplements may not bear disease claims (ie

    capable of curing, treating or preventingdisease); either explicit or implied

    Allowed to be indicated as Dietary / Food/Nutritional Supplement

    Function claims which describe thephysiological role of the nutrient in normalfunctioning of the body may be permitted

  • 8/7/2019 Slides TanLie Sie

    18/27

    REGISTRATIONPROCESS

    On-line registration process (singlestage)

    Implementation of the on-line registrationsystem :

    1 July 20031 July 2003 - for pharmaceuticals(generics), and the OTC products

    1 January 20041 January 2004 - for traditional products

    1 Mac 20041 Mac 2004 - targeted date for the NCEand Biotech products

  • 8/7/2019 Slides TanLie Sie

    19/27

    Flow Chart of Registration Process

    (Pre-market Approval)

    Legal Requirements

    Guidelines, Criteria,

    Process (abridged)

    Quality test fortraditional products

    Obtain smart card

    JKPP

    Applicant

    BPFK evaluate

    application

    Request for

    additional info

    Prepare evaluationreport

    Request for

    additional

    info

    Secretariat

    Not

    satisfactorySatisfactory

    Report

    complete

    Report

    incomplete

    DCA

    Input data & submit

  • 8/7/2019 Slides TanLie Sie

    20/27

  • 8/7/2019 Slides TanLie Sie

    21/27

  • 8/7/2019 Slides TanLie Sie

    22/27

    REGISTRATIONPROCESS

    Unique registration no MAL20001198X

    Registration for a maximum period of 5years

    Updating of product information

    Re-register before expiry of term to bemaintained on product register

  • 8/7/2019 Slides TanLie Sie

    23/27

    CONCERNS

    Consumer perception that a product in theform of a medicineis perceived to be a drugfor treatment

    Responsible information provision. There ispotential high risk to consumers as a result ofinsufficient or incorrect information, orfraudulent products.

    - Although a product may not be toxic or

    dangerous, consumers may compromise theirhealth by not seeking proper medicalattention.

    - Claims about supplements should not divertattention away from eating a healthy diet

  • 8/7/2019 Slides TanLie Sie

    24/27

    CONCLUSION

    There is tremendous interest in anddemand for health supplements and a

    need for regulators to accommodateboth the industry and consumers in

    this area.

  • 8/7/2019 Slides TanLie Sie

    25/27

    CONCLUSION

    However the growing market for

    supplements in a less restrictiveregulatory environment creates the

    potential for supplements to be prone

    to quality-control problems

  • 8/7/2019 Slides TanLie Sie

    26/27

    CONCLUSION

    Authority to regulate and approve

    product registration and licensingthrough pre-market assessment helpsensure that consumers have access tosafe, high quality, properly labeled

    products.

  • 8/7/2019 Slides TanLie Sie

    27/27

    http: // www.bpfk.gov.my